

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.54528165 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.94182452 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.61497940 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.61497940 |
| 5 | response to peptidoglycan (GO:0032494) | 4.40501997 |
| 6 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.15621682 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07174183 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07174183 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.07174183 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07174183 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.07174183 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07174183 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.00078783 |
| 14 | detection of other organism (GO:0098543) | 3.95061494 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.92462384 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.92462384 |
| 17 | respiratory burst (GO:0045730) | 3.90086467 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 3.89916948 |
| 19 | neutrophil activation (GO:0042119) | 3.77539496 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.71454463 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.69054958 |
| 22 | detection of bacterium (GO:0016045) | 3.62141635 |
| 23 | granulocyte activation (GO:0036230) | 3.61827177 |
| 24 | response to interferon-beta (GO:0035456) | 3.60900289 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.60449334 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.56672641 |
| 27 | ribosomal small subunit assembly (GO:0000028) | 3.52287948 |
| 28 | mast cell activation (GO:0045576) | 3.41411209 |
| 29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40204065 |
| 30 | neutrophil mediated immunity (GO:0002446) | 3.39749991 |
| 31 | defense response to protozoan (GO:0042832) | 3.36290290 |
| 32 | cellular response to interferon-beta (GO:0035458) | 3.35393603 |
| 33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.34540948 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.31421693 |
| 35 | microglial cell activation (GO:0001774) | 3.29762500 |
| 36 | response to protozoan (GO:0001562) | 3.22472096 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 3.21915892 |
| 38 | negative regulation of phagocytosis (GO:0050765) | 3.21882284 |
| 39 | regulation of macrophage cytokine production (GO:0010935) | 3.21793652 |
| 40 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.21251754 |
| 41 | positive regulation of interferon-alpha production (GO:0032727) | 3.21175601 |
| 42 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.20762693 |
| 43 | type I interferon signaling pathway (GO:0060337) | 3.19914091 |
| 44 | cellular response to type I interferon (GO:0071357) | 3.19914091 |
| 45 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19584616 |
| 46 | detection of biotic stimulus (GO:0009595) | 3.19330072 |
| 47 | myeloid dendritic cell activation (GO:0001773) | 3.19034309 |
| 48 | superoxide anion generation (GO:0042554) | 3.18239538 |
| 49 | regulation of antigen processing and presentation (GO:0002577) | 3.18236949 |
| 50 | response to muramyl dipeptide (GO:0032495) | 3.17337563 |
| 51 | response to type I interferon (GO:0034340) | 3.16844877 |
| 52 | regulation of mast cell activation (GO:0033003) | 3.15979832 |
| 53 | positive thymic T cell selection (GO:0045059) | 3.14519502 |
| 54 | B cell mediated immunity (GO:0019724) | 3.14404309 |
| 55 | negative thymic T cell selection (GO:0045060) | 3.10516466 |
| 56 | positive regulation of macrophage cytokine production (GO:0060907) | 3.09704367 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.08999857 |
| 58 | negative T cell selection (GO:0043383) | 3.07675265 |
| 59 | regulation of T cell tolerance induction (GO:0002664) | 3.06842643 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 3.06319481 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 3.04648399 |
| 62 | leukocyte aggregation (GO:0070486) | 3.01782195 |
| 63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.00452726 |
| 64 | regulation of tolerance induction (GO:0002643) | 3.00437801 |
| 65 | regulation of mast cell degranulation (GO:0043304) | 2.99816810 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97480870 |
| 67 | response to interleukin-15 (GO:0070672) | 2.96595774 |
| 68 | macrophage activation (GO:0042116) | 2.95644931 |
| 69 | response to interferon-alpha (GO:0035455) | 2.95418397 |
| 70 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.95183744 |
| 71 | leukocyte degranulation (GO:0043299) | 2.95101003 |
| 72 | membrane raft organization (GO:0031579) | 2.93648720 |
| 73 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.93596740 |
| 74 | positive regulation of mast cell degranulation (GO:0043306) | 2.93596740 |
| 75 | macrophage activation involved in immune response (GO:0002281) | 2.92777138 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 2.92128084 |
| 77 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.91240641 |
| 78 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.90447090 |
| 79 | negative regulation of viral genome replication (GO:0045071) | 2.90253023 |
| 80 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90192766 |
| 81 | response to host immune response (GO:0052572) | 2.90192766 |
| 82 | myeloid dendritic cell differentiation (GO:0043011) | 2.90162307 |
| 83 | regulation of leukocyte degranulation (GO:0043300) | 2.89594275 |
| 84 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.87978619 |
| 85 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.87619810 |
| 86 | cellular response to zinc ion (GO:0071294) | 2.86008054 |
| 87 | pinocytosis (GO:0006907) | 2.85930985 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85640639 |
| 89 | regulation of B cell differentiation (GO:0045577) | 2.84122612 |
| 90 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83820493 |
| 91 | leukocyte mediated cytotoxicity (GO:0001909) | 2.83468123 |
| 92 | T cell migration (GO:0072678) | 2.81729812 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 2.81267872 |
| 94 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.80273926 |
| 95 | cellular response to interleukin-15 (GO:0071350) | 2.79583862 |
| 96 | reactive oxygen species biosynthetic process (GO:1903409) | 2.79338023 |
| 97 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78377041 |
| 98 | myeloid leukocyte mediated immunity (GO:0002444) | 2.78355172 |
| 99 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77930118 |
| 100 | positive regulation of mast cell activation (GO:0033005) | 2.77709791 |
| 101 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.77320770 |
| 102 | cellular extravasation (GO:0045123) | 2.76872172 |
| 103 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76212985 |
| 104 | negative regulation of interleukin-12 production (GO:0032695) | 2.76032351 |
| 105 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.75649041 |
| 106 | regulation of monocyte chemotaxis (GO:0090025) | 2.75399190 |
| 107 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.73305025 |
| 108 | myeloid leukocyte activation (GO:0002274) | 2.72700475 |
| 109 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.72320385 |
| 110 | natural killer cell mediated immunity (GO:0002228) | 2.71908133 |
| 111 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.71908133 |
| 112 | regulation of growth of symbiont in host (GO:0044126) | 2.70840023 |
| 113 | negative regulation of growth of symbiont in host (GO:0044130) | 2.70840023 |
| 114 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.70840023 |
| 115 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.70840023 |
| 116 | DNA deamination (GO:0045006) | 2.69535260 |
| 117 | actin nucleation (GO:0045010) | 2.67930168 |
| 118 | response to host (GO:0075136) | 2.66313568 |
| 119 | response to host defenses (GO:0052200) | 2.66313568 |
| 120 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.66313568 |
| 121 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.66027588 |
| 122 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.64851131 |
| 123 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.64441256 |
| 124 | positive regulation of tolerance induction (GO:0002645) | 2.64299985 |
| 125 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.63872719 |
| 126 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.63755436 |
| 127 | positive regulation of macrophage differentiation (GO:0045651) | 2.63394203 |
| 128 | endosome to pigment granule transport (GO:0043485) | 2.61124582 |
| 129 | endosome to melanosome transport (GO:0035646) | 2.61124582 |
| 130 | dendritic cell differentiation (GO:0097028) | 2.60784123 |
| 131 | negative regulation of mast cell activation (GO:0033004) | 2.60098482 |
| 132 | positive regulation of interferon-beta production (GO:0032728) | 2.59968063 |
| 133 | regulation of hypersensitivity (GO:0002883) | 2.58819218 |
| 134 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.58000294 |
| 135 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57560513 |
| 136 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.56357880 |
| 137 | positive regulation of T cell migration (GO:2000406) | 2.54590223 |
| 138 | dendritic cell chemotaxis (GO:0002407) | 2.54154651 |
| 139 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.52910161 |
| 140 | platelet dense granule organization (GO:0060155) | 2.52392332 |
| 141 | mature B cell differentiation involved in immune response (GO:0002313) | 2.50215710 |
| 142 | positive regulation of isotype switching (GO:0045830) | 2.49915243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.17058555 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.06681497 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.87376901 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.72605091 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.00935131 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.63534269 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.54487281 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.17628677 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.09702901 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.07594957 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01961559 |
| 12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.92459344 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.89185167 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81312351 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75523225 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.71588438 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71279878 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.60372588 |
| 19 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.57395706 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.53044991 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.52900331 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.48624848 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45241227 |
| 24 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34698948 |
| 25 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.05734712 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05116121 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02359017 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.99769460 |
| 29 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95591774 |
| 30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93048407 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92629287 |
| 32 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92430934 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89894162 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83831160 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83399303 |
| 36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.80271447 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77124941 |
| 38 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.75219430 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74221007 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69044145 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68886476 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.68405788 |
| 43 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.67600877 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67284839 |
| 45 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.64737215 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.63370755 |
| 47 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62744758 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.62642674 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60501775 |
| 50 | * MAF_26560356_Chip-Seq_TH1_Human | 1.56999142 |
| 51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.56317867 |
| 52 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.54186266 |
| 53 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.48787733 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48003089 |
| 55 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.47768200 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47703613 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46113118 |
| 58 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.44396080 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42329995 |
| 60 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39042715 |
| 61 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.37050183 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36712121 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.36512018 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.35855469 |
| 65 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.35176530 |
| 66 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.34498031 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32466227 |
| 68 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.32083252 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32050401 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32042703 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29440419 |
| 72 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.28205202 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27615326 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 1.27443801 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27036993 |
| 76 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.26485218 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23720307 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23673309 |
| 79 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.23139011 |
| 80 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22480941 |
| 81 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20632481 |
| 82 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20051781 |
| 83 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.19091069 |
| 84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.18176665 |
| 85 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17833375 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16777553 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16767241 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16148948 |
| 89 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15715737 |
| 90 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15061160 |
| 91 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15061160 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15044439 |
| 93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13627668 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10405499 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10312678 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09922507 |
| 97 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08111914 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08066308 |
| 99 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07780714 |
| 100 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04868822 |
| 101 | MAF_26560356_Chip-Seq_TH2_Human | 1.04534231 |
| 102 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03753197 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03237845 |
| 104 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.02249391 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01764959 |
| 106 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00840219 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00334119 |
| 108 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99808505 |
| 109 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99389686 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99151708 |
| 111 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.97348964 |
| 112 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95050866 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93366501 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92628788 |
| 115 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92368551 |
| 116 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91664520 |
| 117 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91101322 |
| 118 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.90924238 |
| 119 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89629357 |
| 120 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.88482830 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88144112 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88144112 |
| 123 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.87997546 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87841769 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85256639 |
| 126 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85054769 |
| 127 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.83913402 |
| 128 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82511520 |
| 129 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80385217 |
| 130 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80251351 |
| 131 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78910785 |
| 132 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.78852175 |
| 133 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78092413 |
| 134 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75400404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.75203852 |
| 2 | MP0009785_altered_susceptibility_to | 3.51797398 |
| 3 | MP0003436_decreased_susceptibility_to | 3.46545159 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.29919273 |
| 5 | MP0005671_abnormal_response_to | 2.98798695 |
| 6 | MP0002419_abnormal_innate_immunity | 2.96504428 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.92259627 |
| 8 | MP0005025_abnormal_response_to | 2.88953026 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.84850967 |
| 10 | MP0000685_abnormal_immune_system | 2.75366224 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.64061848 |
| 12 | MP0005387_immune_system_phenotype | 2.59159518 |
| 13 | MP0001790_abnormal_immune_system | 2.59159518 |
| 14 | MP0001800_abnormal_humoral_immune | 2.58738099 |
| 15 | MP0002723_abnormal_immune_serum | 2.50661628 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.43619665 |
| 17 | MP0001819_abnormal_immune_cell | 2.43524704 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.42682176 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.42409079 |
| 20 | MP0003724_increased_susceptibility_to | 2.22161700 |
| 21 | MP0005174_abnormal_tail_pigmentation | 2.21426209 |
| 22 | MP0003303_peritoneal_inflammation | 2.20858783 |
| 23 | MP0006082_CNS_inflammation | 2.14940306 |
| 24 | MP0002398_abnormal_bone_marrow | 2.06797772 |
| 25 | MP0003279_aneurysm | 2.05356557 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.04043300 |
| 27 | MP0002405_respiratory_system_inflammati | 2.02923800 |
| 28 | MP0001853_heart_inflammation | 2.01793602 |
| 29 | MP0001958_emphysema | 1.98359699 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.97764398 |
| 31 | MP0002006_tumorigenesis | 1.97650855 |
| 32 | MP0000716_abnormal_immune_system | 1.95700237 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.92815499 |
| 34 | MP0006054_spinal_hemorrhage | 1.91886778 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.91255983 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.88408123 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.88408123 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.83793230 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.77831843 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.74008402 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.73705153 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.67929321 |
| 43 | MP0000490_abnormal_crypts_of | 1.67836038 |
| 44 | MP0002429_abnormal_blood_cell | 1.65939560 |
| 45 | MP0002722_abnormal_immune_system | 1.64740519 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.64191725 |
| 47 | MP0000015_abnormal_ear_pigmentation | 1.62812000 |
| 48 | MP0000858_altered_metastatic_potential | 1.61610578 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.56751594 |
| 50 | MP0009278_abnormal_bone_marrow | 1.55245435 |
| 51 | MP0004510_myositis | 1.52262220 |
| 52 | MP0003693_abnormal_embryo_hatching | 1.50920392 |
| 53 | MP0009764_decreased_sensitivity_to | 1.49020754 |
| 54 | MP0005310_abnormal_salivary_gland | 1.48115892 |
| 55 | MP0001542_abnormal_bone_strength | 1.46725524 |
| 56 | MP0003091_abnormal_cell_migration | 1.43638696 |
| 57 | MP0003448_altered_tumor_morphology | 1.43458091 |
| 58 | MP0005164_abnormal_response_to | 1.43451938 |
| 59 | MP0005275_abnormal_skin_tensile | 1.43326182 |
| 60 | MP0008469_abnormal_protein_level | 1.43325795 |
| 61 | MP0004947_skin_inflammation | 1.42742633 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 1.42124545 |
| 63 | MP0000343_altered_response_to | 1.40357446 |
| 64 | MP0001873_stomach_inflammation | 1.39728447 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.38317675 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.37428852 |
| 67 | MP0004883_abnormal_blood_vessel | 1.35474510 |
| 68 | MP0005023_abnormal_wound_healing | 1.27232349 |
| 69 | MP0008058_abnormal_DNA_repair | 1.26794401 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.21976985 |
| 71 | MP0003300_gastrointestinal_ulcer | 1.19779516 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.18800318 |
| 73 | MP0003866_abnormal_defecation | 1.18194631 |
| 74 | MP0002095_abnormal_skin_pigmentation | 1.15900861 |
| 75 | MP0008057_abnormal_DNA_replication | 1.14763874 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 1.12571380 |
| 77 | MP0000569_abnormal_digit_pigmentation | 1.11089011 |
| 78 | MP0010094_abnormal_chromosome_stability | 1.10793580 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 1.08690094 |
| 80 | MP0010307_abnormal_tumor_latency | 1.08142710 |
| 81 | MP0000604_amyloidosis | 1.07002749 |
| 82 | MP0003950_abnormal_plasma_membrane | 1.06980318 |
| 83 | MP0002933_joint_inflammation | 1.06966713 |
| 84 | MP0003111_abnormal_nucleus_morphology | 1.04406425 |
| 85 | MP0000767_abnormal_smooth_muscle | 1.02442670 |
| 86 | MP0002998_abnormal_bone_remodeling | 1.01454999 |
| 87 | MP0003045_fibrosis | 0.99734601 |
| 88 | MP0003077_abnormal_cell_cycle | 0.98275176 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.97651909 |
| 90 | * MP0002019_abnormal_tumor_incidence | 0.95961610 |
| 91 | MP0003186_abnormal_redox_activity | 0.95280902 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.93234780 |
| 93 | MP0000371_diluted_coat_color | 0.92600567 |
| 94 | MP0005165_increased_susceptibility_to | 0.92004221 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.91223444 |
| 96 | MP0009763_increased_sensitivity_to | 0.87232305 |
| 97 | MP0008004_abnormal_stomach_pH | 0.86915208 |
| 98 | MP0005390_skeleton_phenotype | 0.84372795 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.83366663 |
| 100 | MP0002060_abnormal_skin_morphology | 0.80973962 |
| 101 | MP0002132_abnormal_respiratory_system | 0.80111439 |
| 102 | MP0003828_pulmonary_edema | 0.77754764 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.75084578 |
| 104 | MP0002009_preneoplasia | 0.72342742 |
| 105 | MP0003690_abnormal_glial_cell | 0.71859511 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.71655937 |
| 107 | MP0001243_abnormal_dermal_layer | 0.71394828 |
| 108 | MP0003075_altered_response_to | 0.71103836 |
| 109 | * MP0000313_abnormal_cell_death | 0.69106252 |
| 110 | MP0005388_respiratory_system_phenotype | 0.68984531 |
| 111 | MP0002133_abnormal_respiratory_system | 0.68984531 |
| 112 | MP0008260_abnormal_autophagy | 0.68330714 |
| 113 | MP0001851_eye_inflammation | 0.68324639 |
| 114 | MP0005595_abnormal_vascular_smooth | 0.66811296 |
| 115 | MP0005451_abnormal_body_composition | 0.66677636 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.66450418 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.66102930 |
| 118 | MP0010386_abnormal_urinary_bladder | 0.65102230 |
| 119 | MP0005166_decreased_susceptibility_to | 0.65010165 |
| 120 | MP0003795_abnormal_bone_structure | 0.63661257 |
| 121 | MP0000372_irregular_coat_pigmentation | 0.63114733 |
| 122 | MP0001663_abnormal_digestive_system | 0.62918938 |
| 123 | MP0003786_premature_aging | 0.62742699 |
| 124 | MP0000249_abnormal_blood_vessel | 0.59155484 |
| 125 | MP0009840_abnormal_foam_cell | 0.58219077 |
| 126 | MP0002075_abnormal_coat/hair_pigmentati | 0.56345892 |
| 127 | MP0003943_abnormal_hepatobiliary_system | 0.56144322 |
| 128 | MP0001186_pigmentation_phenotype | 0.54583020 |
| 129 | MP0000681_abnormal_thyroid_gland | 0.54031599 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.52722173 |
| 131 | MP0006292_abnormal_olfactory_placode | 0.52667245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.07137660 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.34569859 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.29744778 |
| 4 | Myositis (HP:0100614) | 4.72914878 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.53108983 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.17098454 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.97613196 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 3.89016496 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 3.86384907 |
| 10 | Obstructive lung disease (HP:0006536) | 3.86384907 |
| 11 | Optic neuritis (HP:0100653) | 3.78884448 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.78884448 |
| 13 | Orchitis (HP:0100796) | 3.74884523 |
| 14 | Thrombocytosis (HP:0001894) | 3.74016034 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.72837753 |
| 16 | Spondylolisthesis (HP:0003302) | 3.70633411 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.67907194 |
| 18 | T lymphocytopenia (HP:0005403) | 3.58669938 |
| 19 | Recurrent skin infections (HP:0001581) | 3.49845238 |
| 20 | Peritonitis (HP:0002586) | 3.35946444 |
| 21 | Petechiae (HP:0000967) | 3.28885002 |
| 22 | IgM deficiency (HP:0002850) | 3.27506911 |
| 23 | Chronic otitis media (HP:0000389) | 3.26028657 |
| 24 | Meningitis (HP:0001287) | 3.23987927 |
| 25 | Gingivitis (HP:0000230) | 3.20591443 |
| 26 | Recurrent viral infections (HP:0004429) | 3.20131959 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.12957839 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07876549 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07876549 |
| 30 | Vasculitis (HP:0002633) | 3.01099006 |
| 31 | Abnormality of the prostate (HP:0008775) | 3.00644074 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 2.94385054 |
| 33 | Stomatitis (HP:0010280) | 2.93823846 |
| 34 | Aortic dissection (HP:0002647) | 2.91786629 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91744105 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 2.85404823 |
| 37 | Protrusio acetabuli (HP:0003179) | 2.83359129 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.81361274 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.80582696 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 2.80276078 |
| 41 | Prostate neoplasm (HP:0100787) | 2.78961536 |
| 42 | Premature rupture of membranes (HP:0001788) | 2.76006844 |
| 43 | Basal ganglia calcification (HP:0002135) | 2.72451275 |
| 44 | Prolonged bleeding time (HP:0003010) | 2.72397942 |
| 45 | Periodontitis (HP:0000704) | 2.68870113 |
| 46 | Pustule (HP:0200039) | 2.61598875 |
| 47 | Chromsome breakage (HP:0040012) | 2.59758372 |
| 48 | Granulocytopenia (HP:0001913) | 2.58789236 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.57136301 |
| 50 | Cellulitis (HP:0100658) | 2.56846378 |
| 51 | Amyloidosis (HP:0011034) | 2.56011761 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.55833716 |
| 53 | Reticulocytopenia (HP:0001896) | 2.54264981 |
| 54 | Encephalitis (HP:0002383) | 2.54017731 |
| 55 | Eosinophilia (HP:0001880) | 2.53786486 |
| 56 | Leukocytosis (HP:0001974) | 2.53349403 |
| 57 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.52238678 |
| 58 | Increased IgM level (HP:0003496) | 2.50344726 |
| 59 | Recurrent pneumonia (HP:0006532) | 2.48212021 |
| 60 | Panhypogammaglobulinemia (HP:0003139) | 2.48118855 |
| 61 | Abnormality of T cells (HP:0002843) | 2.45178899 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.44989980 |
| 63 | Aortic aneurysm (HP:0004942) | 2.44440019 |
| 64 | Epistaxis (HP:0000421) | 2.39520864 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.38984731 |
| 66 | Dilatation of the ascending aorta (HP:0005111) | 2.37607325 |
| 67 | Type I transferrin isoform profile (HP:0003642) | 2.37192944 |
| 68 | Arterial thrombosis (HP:0004420) | 2.36057834 |
| 69 | Recurrent bronchitis (HP:0002837) | 2.35394009 |
| 70 | Hemoptysis (HP:0002105) | 2.34221853 |
| 71 | Gingival bleeding (HP:0000225) | 2.31444309 |
| 72 | Spontaneous hematomas (HP:0007420) | 2.30811939 |
| 73 | Agnosia (HP:0010524) | 2.28250100 |
| 74 | Recurrent lower respiratory tract infections (HP:0002783) | 2.28195264 |
| 75 | IgG deficiency (HP:0004315) | 2.28136511 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.25287397 |
| 77 | Abnormality of the pericardium (HP:0001697) | 2.25238673 |
| 78 | Abnormality of eosinophils (HP:0001879) | 2.24356214 |
| 79 | Hypergammaglobulinemia (HP:0010702) | 2.23516072 |
| 80 | Albinism (HP:0001022) | 2.23125974 |
| 81 | Keratoconjunctivitis (HP:0001096) | 2.22078264 |
| 82 | Spinal cord lesions (HP:0100561) | 2.21340878 |
| 83 | Syringomyelia (HP:0003396) | 2.21340878 |
| 84 | Urticaria (HP:0001025) | 2.19151132 |
| 85 | Cheilitis (HP:0100825) | 2.18680796 |
| 86 | Vascular tortuosity (HP:0004948) | 2.17382580 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16868556 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16868556 |
| 89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16868556 |
| 90 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16252968 |
| 91 | Mucopolysacchariduria (HP:0008155) | 2.16252968 |
| 92 | Osteomyelitis (HP:0002754) | 2.16172869 |
| 93 | Clubbing of toes (HP:0100760) | 2.15687380 |
| 94 | Aplastic anemia (HP:0001915) | 2.15656389 |
| 95 | Atrophic scars (HP:0001075) | 2.13370764 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.12612334 |
| 97 | Hematochezia (HP:0002573) | 2.10947917 |
| 98 | Impaired platelet aggregation (HP:0003540) | 2.10749949 |
| 99 | Abnormal platelet function (HP:0011869) | 2.10749949 |
| 100 | Abnormality of the peritoneum (HP:0002585) | 2.10696868 |
| 101 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10255692 |
| 102 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10255692 |
| 103 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10255692 |
| 104 | Interstitial pulmonary disease (HP:0006530) | 2.09713624 |
| 105 | Chest pain (HP:0100749) | 2.07468456 |
| 106 | Episodic fever (HP:0001954) | 2.06842497 |
| 107 | Arterial tortuosity (HP:0005116) | 2.06383763 |
| 108 | Pulmonary embolism (HP:0002204) | 2.05954374 |
| 109 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05379190 |
| 110 | Vertebral compression fractures (HP:0002953) | 2.04168546 |
| 111 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.03707323 |
| 112 | Lymphoma (HP:0002665) | 2.03377383 |
| 113 | Lymphopenia (HP:0001888) | 2.03145295 |
| 114 | Increased IgE level (HP:0003212) | 2.03000430 |
| 115 | Thyroiditis (HP:0100646) | 2.00213909 |
| 116 | Gangrene (HP:0100758) | 1.99526528 |
| 117 | Chronic diarrhea (HP:0002028) | 1.98955776 |
| 118 | Abnormality of T cell number (HP:0011839) | 1.96691511 |
| 119 | Hepatosplenomegaly (HP:0001433) | 1.96648838 |
| 120 | Acute myeloid leukemia (HP:0004808) | 1.96295861 |
| 121 | Abnormality of B cell number (HP:0010975) | 1.95402400 |
| 122 | B lymphocytopenia (HP:0010976) | 1.95402400 |
| 123 | Myelodysplasia (HP:0002863) | 1.95119916 |
| 124 | Skin ulcer (HP:0200042) | 1.94458313 |
| 125 | Glomerulopathy (HP:0100820) | 1.92831985 |
| 126 | Loss of speech (HP:0002371) | 1.91985662 |
| 127 | Pulmonary fibrosis (HP:0002206) | 1.91145431 |
| 128 | Acrocyanosis (HP:0001063) | 1.90396868 |
| 129 | Agammaglobulinemia (HP:0004432) | 1.89999564 |
| 130 | Nasal polyposis (HP:0100582) | 1.89848831 |
| 131 | Abnormality of the pleura (HP:0002103) | 1.89520599 |
| 132 | Myocardial infarction (HP:0001658) | 1.89387246 |
| 133 | Neutropenia (HP:0001875) | 1.88079109 |
| 134 | Abnormal glycosylation (HP:0012345) | 1.87158615 |
| 135 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87158615 |
| 136 | Anorexia (HP:0002039) | 1.87134751 |
| 137 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86111993 |
| 138 | Osteolytic defects of the hand bones (HP:0009699) | 1.86111993 |
| 139 | Cervical subluxation (HP:0003308) | 1.83662998 |
| 140 | Joint stiffness (HP:0001387) | 1.83533527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 3.93706161 |
| 2 | IRAK3 | 3.62504313 |
| 3 | MAP4K1 | 3.11134420 |
| 4 | TXK | 3.09120288 |
| 5 | KIT | 2.90683412 |
| 6 | MAP3K14 | 2.86188162 |
| 7 | TEC | 2.67773293 |
| 8 | BLK | 2.48331260 |
| 9 | TBK1 | 2.39594307 |
| 10 | PIM2 | 2.25260084 |
| 11 | ZAK | 2.25242394 |
| 12 | IKBKE | 2.25147772 |
| 13 | RIPK4 | 2.20403711 |
| 14 | NME2 | 2.15474616 |
| 15 | IKBKB | 2.11425903 |
| 16 | JAK3 | 2.10555048 |
| 17 | STK16 | 2.08275191 |
| 18 | BTK | 2.04569996 |
| 19 | TYK2 | 2.04297438 |
| 20 | GRK7 | 1.79539914 |
| 21 | ZAP70 | 1.74474121 |
| 22 | TAOK3 | 1.73945256 |
| 23 | MAP3K3 | 1.67250162 |
| 24 | SYK | 1.60742255 |
| 25 | PRPF4B | 1.58424184 |
| 26 | MOS | 1.51452825 |
| 27 | CSF1R | 1.44917323 |
| 28 | PIM1 | 1.38395640 |
| 29 | MYLK | 1.37529291 |
| 30 | EIF2AK3 | 1.35873050 |
| 31 | RPS6KA4 | 1.30249200 |
| 32 | MAP2K3 | 1.28496992 |
| 33 | PLK4 | 1.27979080 |
| 34 | LYN | 1.25466491 |
| 35 | ACVR1B | 1.23975893 |
| 36 | FES | 1.22155770 |
| 37 | CHUK | 1.21884216 |
| 38 | EIF2AK2 | 1.21679926 |
| 39 | NEK9 | 1.19378607 |
| 40 | FLT3 | 1.17377332 |
| 41 | HCK | 1.16027747 |
| 42 | TTN | 1.14452389 |
| 43 | FGR | 1.13516122 |
| 44 | JAK1 | 1.11750644 |
| 45 | MAP3K12 | 1.10830395 |
| 46 | LCK | 1.09335364 |
| 47 | CLK1 | 1.07316542 |
| 48 | EPHB1 | 1.07227880 |
| 49 | DDR2 | 0.99704332 |
| 50 | TRPM7 | 0.99568058 |
| 51 | ITK | 0.97714673 |
| 52 | STK4 | 0.96947313 |
| 53 | MATK | 0.94795963 |
| 54 | YES1 | 0.94609427 |
| 55 | PRKD2 | 0.92458251 |
| 56 | PBK | 0.92203026 |
| 57 | TESK1 | 0.89286100 |
| 58 | ADRBK2 | 0.87399125 |
| 59 | ATR | 0.85246828 |
| 60 | MAP3K1 | 0.83925982 |
| 61 | WEE1 | 0.82081768 |
| 62 | CSK | 0.81731656 |
| 63 | TGFBR2 | 0.81327103 |
| 64 | MAPK7 | 0.80166087 |
| 65 | SIK3 | 0.79943549 |
| 66 | MAP3K11 | 0.78619419 |
| 67 | IRAK1 | 0.77590031 |
| 68 | STK10 | 0.76243436 |
| 69 | LIMK1 | 0.75880331 |
| 70 | NLK | 0.75736599 |
| 71 | VRK1 | 0.75308586 |
| 72 | TNK2 | 0.74627809 |
| 73 | SCYL2 | 0.69606447 |
| 74 | PIK3CG | 0.67563842 |
| 75 | CDK6 | 0.66847511 |
| 76 | MARK3 | 0.66434711 |
| 77 | CDC42BPA | 0.66304546 |
| 78 | PAK2 | 0.65741576 |
| 79 | BUB1 | 0.64717119 |
| 80 | TGFBR1 | 0.64669510 |
| 81 | TNIK | 0.64548980 |
| 82 | IRAK2 | 0.64178659 |
| 83 | MKNK1 | 0.64045294 |
| 84 | KDR | 0.61982645 |
| 85 | EIF2AK1 | 0.60771741 |
| 86 | BMPR2 | 0.59402294 |
| 87 | PTK2B | 0.58380045 |
| 88 | PRKCD | 0.56321015 |
| 89 | PDGFRB | 0.55626905 |
| 90 | PRKCQ | 0.54500495 |
| 91 | FYN | 0.53275444 |
| 92 | PDK1 | 0.53028906 |
| 93 | ABL1 | 0.52432270 |
| 94 | TESK2 | 0.52273115 |
| 95 | MUSK | 0.52160745 |
| 96 | ERN1 | 0.51889632 |
| 97 | MAP3K13 | 0.51205181 |
| 98 | KSR2 | 0.50991049 |
| 99 | PDGFRA | 0.50750435 |
| 100 | RPS6KB2 | 0.50716652 |
| 101 | LRRK2 | 0.49537024 |
| 102 | BMPR1B | 0.47765578 |
| 103 | MAP3K5 | 0.47761522 |
| 104 | ARAF | 0.47611364 |
| 105 | CDK4 | 0.46571649 |
| 106 | ABL2 | 0.44996723 |
| 107 | BRSK2 | 0.44750266 |
| 108 | JAK2 | 0.44609356 |
| 109 | NEK2 | 0.44130709 |
| 110 | RPS6KA6 | 0.43770548 |
| 111 | MAPKAPK2 | 0.43626303 |
| 112 | MST4 | 0.43183135 |
| 113 | SRPK1 | 0.41279078 |
| 114 | PRKG2 | 0.41278791 |
| 115 | INSR | 0.40510518 |
| 116 | RAF1 | 0.40367830 |
| 117 | CAMKK2 | 0.39969811 |
| 118 | CDK8 | 0.39013850 |
| 119 | MAP3K2 | 0.38993359 |
| 120 | RIPK1 | 0.38936401 |
| 121 | CDK7 | 0.38900945 |
| 122 | TAOK1 | 0.38394155 |
| 123 | NUAK1 | 0.38392912 |
| 124 | RPS6KC1 | 0.38356492 |
| 125 | RPS6KL1 | 0.38356492 |
| 126 | RPS6KA5 | 0.38059147 |
| 127 | TAOK2 | 0.37441546 |
| 128 | MKNK2 | 0.36331620 |
| 129 | MAP3K6 | 0.35895485 |
| 130 | SIK2 | 0.35798534 |
| 131 | IGF1R | 0.35743688 |
| 132 | DYRK3 | 0.35535178 |
| 133 | MAPK12 | 0.35443472 |
| 134 | PDPK1 | 0.35272007 |
| 135 | MAP2K6 | 0.35249530 |
| 136 | MAPK4 | 0.35114204 |
| 137 | PAK4 | 0.34900719 |
| 138 | GRK6 | 0.34695846 |
| 139 | ERBB3 | 0.34689662 |
| 140 | FGFR3 | 0.33612268 |
| 141 | CCNB1 | 0.33465648 |
| 142 | STK38 | 0.33174938 |
| 143 | EGFR | 0.32719448 |
| 144 | RPS6KA2 | 0.32625236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.76109291 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.70988744 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.38429734 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.36633934 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34438171 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.13311280 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.12518603 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11144040 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.10429220 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.04861337 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.00112573 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.97793839 |
| 13 | Asthma_Homo sapiens_hsa05310 | 1.96968523 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.85980779 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85109545 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.84363294 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.82085189 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76847872 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.76770620 |
| 20 | Mismatch repair_Homo sapiens_hsa03430 | 1.74607047 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.72894774 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66937082 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.66258089 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.65786594 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.65694491 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63936492 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.58007184 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.54922464 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.51276513 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46443298 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.44360786 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42888655 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35774302 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.35021222 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33192088 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.33160402 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31444337 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29185018 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.27226116 |
| 40 | Proteasome_Homo sapiens_hsa03050 | 1.26247040 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.22396194 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21929045 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19915783 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.17653055 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.08658914 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06481927 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06274474 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 1.06174739 |
| 49 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.05464796 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.05314690 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.02517505 |
| 52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00176247 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98235120 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97794014 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.97342807 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94463818 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93964344 |
| 58 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.93752712 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92908374 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91869385 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90443183 |
| 62 | RNA polymerase_Homo sapiens_hsa03020 | 0.89920940 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88495408 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87531974 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84812167 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84183043 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82006048 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78474317 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78018595 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76476367 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.76392536 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75338280 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74604462 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.72570925 |
| 75 | Spliceosome_Homo sapiens_hsa03040 | 0.72354365 |
| 76 | Cell cycle_Homo sapiens_hsa04110 | 0.71857690 |
| 77 | Protein export_Homo sapiens_hsa03060 | 0.71228032 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69179509 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.68844647 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62630035 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.62491921 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62013892 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.61458853 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59449309 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58878331 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57258100 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56558535 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56472815 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.55674015 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55155806 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54439829 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53991541 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53726069 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53269572 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53096410 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51886840 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51495961 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51321025 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50647800 |
| 100 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49815039 |
| 101 | RNA degradation_Homo sapiens_hsa03018 | 0.49778278 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47829387 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47118400 |
| 104 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46215119 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45339434 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43389545 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43232086 |
| 108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42777745 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42711199 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.42209364 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40223062 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35562569 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35487409 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35314038 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34400790 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32285815 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31994327 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30566767 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29855303 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29757553 |
| 121 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.29544386 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28363323 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28334452 |
| 124 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26414671 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25019147 |
| 126 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.24746849 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.23151286 |
| 128 | Prostate cancer_Homo sapiens_hsa05215 | 0.21592403 |

